News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
‘Molecular clock’ blood test could track spread of breast cancer
A blood test to watch breast cancer’s ‘molecular clock’ could help track the growth of multiple tumours around the body and monitor how they are responding to treatment, new research suggests.
Video for schools shows how scientists create new cancer treatments
Cancer researchers talk about their pioneering work to discover and develop new drugs in a new video for schools and students designed to bring the GCSE curriculum on the creation of new treatments to life.
Pioneering centre for 'Darwinian' cancer drug discovery opens to researchers
A world-first new centre aiming to overcome cancer’s ability to evolve and become resistant to once effective treatments has opened its doors to researchers. Scientists at the new Centre for Cancer Drug Discovery hope their approaches will mean long-term control of cancer, as well as cures.
Blood test picks out cancers likely to benefit from targeted drugs
A simple and inexpensive blood test could pick out patients with stomach or oesophageal cancer who are likely to benefit from targeted treatment, a new study shows.
Pipette painting marks pioneering cancer research
Street artist James Cochran has created a 50,000-dot painting using a lab pipette – to illustrate pioneering new research which will be undertaken in the ICR's new Centre for Cancer Drug Discovery.
Vary drug prices for different conditions, say health experts
The NHS could improve patients’ access to new cancer treatments by paying different prices for drugs depending on the disease they are used to treat, concludes a group of experts from across academia and industry.
Prostate cancer drug targeting Achilles heel approved in Europe
The Institute of Cancer Research, London, has strongly welcomed the approval by the European Commission of the targeted drug olaparib for men with advanced prostate cancers with genetic alterations in BRCA1 or BRCA2.
NCRI 2020: New bowel cancer model uncovering how it avoids immunotherapy drug
Scientists at The Institute of Cancer Research, London, have developed a complex model system that mimics the most common form of bowel cancer and is showing how it ‘hides’ from immunotherapy.
Low-cost test could pick out breast cancer patients at increased risk of relapse
Testing women’s response to hormone therapy for breast cancer given around the time of surgery could be a fast and cheap way of predicting how likely the disease is to come back, a major clinical trial has found.
ICR welcomes NICE’s decision to reassess abiraterone as first-line treatment for advanced prostate cancer
The Institute of Cancer Research, London, has welcomed the announcement by NICE that it will reconsider its decision not to recommend abiraterone as a first-line treatment for newly diagnosed, advanced prostate cancer.
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers
A new drug designed to counter the effects of an important, but very hard to target, cancer mutation could be effective against a range of tumour types including lung and gynaecological cancers, a new clinical trial shows.
ICR calls for change to bring immunotherapies to more cancer patients
Major changes to the way immunotherapy drugs are researched and evaluated are essential if they are to become successful treatment options for many more types of cancers, leading cancer experts are warning.
